Journal
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
Volume 33, Issue 2, Pages 301-+Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.hoc.2018.12.006
Keywords
Head and neck cancer; Squamous cell carcinoma; Immunotherapy; Checkpoint inhibitor; Oncolytic virus; Adoptive T-cell transfer
Categories
Ask authors/readers for more resources
The immune system has a vital role in the development, establishment, and progression of head and neck squamous cell carcinoma (HNSCC). Immune evasion of cancer cells leads to progression of HNSCC. An understanding of this mechanism provides the basis for improved therapies and outcomes for patients. Through the tumor's influence on the microenvironment, the immune system can be exploited to promote metastasis, angiogenesis, and growth. This article provides an overview of the interaction between immune infiltrating cells in the tumor microenvironment, and the immunologic principles related to HNSCC. Current immunotherapeutic strategies and emerging results from ongoing clinical trials are presented.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available